LysoPC (20:4)

LysoPC (20:4) is a type of lysophosphatidylcholine. The level of LysoPC (20:4) is negatively correlated with cancer risk. LysoPC (20:4) may promote tumor progression through the lysophosphatidic acid (LPA) signaling pathway[1].

Product Specifications

CAS Number

[60701-99-7]

Product Name Alternative

1-Arachidonoyl-sn-glycero-3-phosphocholine

UNSPSC

12352211

Target

Endogenous Metabolite

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cancer

Smiles

C[N+](C)(C)CCOP(OC[C@H](O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)([O-])=O

Molecular Formula

C28H50NO7P

Molecular Weight

543.67

References & Citations

[1]Kühn T, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016 Jan 28;14:13.